Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	32.42	122.53	-92.53
Graham Fair Price	-55.58	0.93	2.09
PEG	149.53	-0.28	0.11
Price/Book	-23.40	0.37	0.48
Price/Cash Flow	63.45	-105.05	-287.39
Prices/Earnings	290.51	32.73	-8.38
Price/Sales	-39.81	5.92	9.83
Price/FCF	63.45	-105.05	-287.39
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	611.23	0.32	0.05
Operating Margin	-71.59	0.08	-0.29
ROA	-79.88	< 0.005	< 0.005
ROE	-0.01	< 0.005	-80.38
ROIC	< 0.005	< 0.005	-83.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	< 0.005	-22.29
Dividends QOQ	-0.79	-0.43	45.29
EBIT QOQ	0.80	1.36	69.59
EPS QOQ	0.76	1.19	56.50
FCF QOQ	0.70	-1.93	175.23
Revenue QOQ	-0.09	0.28	219.42
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	138.76	155.72	12.23
Days Sales Outstanding (DSO)	1880.60	1400.48	-25.53
Inventory Turnover	0.65	0.58	-10.90
Debt/Capitalization	0.50	0.49	-0.36
Quick Ratio	0.84	0.86	2.34
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	3.68	3.84	4.54
Cash	1.44	1.46	0.84
Capex	< 0.005	< 0.005	32.52
Free Cash Flow	< 0.005	-0.01	-110.20
Revenue	0.18	0.23	27.66
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.90	0.90	-0.08
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-50.19	74.34	48.11
Naive Interpretation	Member

06 - Financial Health · Bad

Rating